Virtual Investor Event

Virtual Event | Now Available on Demand

Watch on Demand

CENTOGENE Biodatabank Loop Light

Agenda

9:00 a.m. EDT

Welcome

Strategy Update

Andrin Oswald, CEO

Building the Leading Bio/Databank in Rare Diseases

Bettina Goerner, CDO

Superior Genomics Insights for Clinical Diagnostics

Max Schmid, CCO Diagnostics
Peter Bauer, CGO

Enabling and Accelerating Orphan Drug Development

Michael Motz, CCO Pharmaceuticals
Justin Bingham, SVP Business Development

Unlocking the Complexity of Rare Diseases with Multiomics

Volkmar Weckesser, CIO
Claudia Cozma, VP Biomarkers
Philip Lambert, CSO

Finance Priorities and Process Optimization

René Just, CFO

Q&A
 

11:00 a.m. EDT

Closing

CENTOGENE Virtual Investor Day Banner DNA

Subscribe to Receive Updates From CENTOGENE

Subscribe now

Speakers

CENTOGENE Executive Board Bettina Goerner

Bettina Goerner

Chief Data Officer

Bettina serves as CENTOGENE’s Chief Data Officer (CDO). Bringing 15 years of […]

Maximilian Schmid, M.D., CENTOGENE’s Chief Commercial Officer Diagnostics

Maximilian Schmid, M.D.

Chief Commercial Officer – Diagnostics

Max serves as CENTOGENE’s Chief Commercial Officer Diagnostics. Bringing over two […]

Prof. Peter Bauer,  M.D., CENTOGENE's Chief Genomic Officer

Prof. Peter Bauer, M.D.

Chief Genomic Officer

Prof. Peter Bauer, M.D., serves as CENTOGENE's Chief Genomic Officer, where he combines […]

CENTOGENE Executive Board Justin Bingham

Justin Bingham

Vice President Business Development

Justin, as Senior Vice President of Business Development at CENTOGENE, leads a global […]

CENTOGENE Webinar Speaker Volkmar Weckesser

Volkmar Weckesser, Ph.D.

Chief Information Officer

Dr. Volkmar Weckesser ist seit 2016 Chief Information Officer (CIO) der Centogene AG in […]

CENTOGENE Executive Board Claudia Cozma

Claudia Cozma, Ph.D.

Vice President Biomarker Development

Dr. Claudia Cozma is the Vice President of the Biomarker Development team at CENTOGENE […]

CENTOGENE Executive Board Philip Lambert

Philip Lambert

Chief Scientific Officer

With over two decades of scientific and operational experience in the drug discovery […]

Miguel Coego Rios, CENTOGENE’s Chief Financial Officer

Miguel Coego Rios

Interim Chief Financial Officer and EVP Finance & Legal

Miguel Coego Rios is an experienced senior executive with broad expertise in finance […]

Press Release

Jun 22,  2021

CENTOGENE Sets Mission to Enable the Cure of 100 Rare Diseases Within the Next 10 Years

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 22, 2021 (GLOBE NEWSWIRE) Highlights strategic priorities to...

Read More

Event Presentation

CENTOGENE Investor Event Presentation

Virtual Investor Event Presentation

CENTOGENE Virtual Investor Day Banner DNA

Watch Our Virtual Investor Event on Demand

Watch on Demand

Virtual Investor Event – Listen on Demand

Event Program – Audio on Demand
Q&A Session – Audio on Demand

Contact Us

CENTOGENE Investor Relations 

For more information, contact our IR team.

Contact IR

Disclaimer & Safe Harbor

CENTOGENE Statement Virtual Investor Day

Safe Harbor Statement